Magnesium Sulphate for Fetal Neuroprotection at Imminent Risk for Preterm Delivery: A Systematic Review With Meta-analysis and Trial Sequential Analysis. Issue 3 (March 2021)

• Record Type: Journal Article
• Authors: Wolf, H. T.; Huusom, L. D.; Henriksen, T. B.; Hegaard, H. K.; Brok, J.; Pinborg, A.
• Is Part Of: Obstetrical & gynecological survey. Volume 76:Issue 3(2021)
• Page Start: 135
• Page End: 137
• Publication Date: 2021-03
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000742392.94203.52
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from BJOG 2020;127:1180–1188) Preterm delivery puts infants at risk of developing cerebral palsy (CP). Conventional meta-analyses have shown that administering magnesium sulfate (MgSO4 ) at imminent preterm birth may help decrease this risk.